Skip to main content
. 2020 Jan 6;20:11. doi: 10.1186/s12885-019-6466-7

Table 1.

Univariate and multivariate analyses of clinicopathological variables in relation to overall survival in patients undergoing potentially curative resection for gastric cancer

Clinicopathological features Univariate analysis Multivariate analysis
HR (95% CI) P HR (95% CI) P
Age 1.03 (1.02–1.04) < 0.001 1.02 (1.01–1.03) < 0.001
Sex 0.979
 Male Reference
 Female 1.00 (0.83–1.21)
BMI 0.94 (0.92–0.97) < 0.001 0.058
ASA score 0.013 0.740
 1 Reference
 2 1.29 (1.09–1.53)
 3 1.18 (0.75–1.86)
Tumor location < 0.001 < 0.001
 Upper Reference Reference
 Middle 1.05 (0.83–1.33) 0.92 (0.72–1.17)
 Lower 0.59 (0.48–0.73) 0.79 (0.64–0.97)
 Mixed 1.56 (1.22–1.98) 1.32 (1.03–1.70)
Tumor size (cm) 1.02 (1.01–1.02) < 0.001 1.01 (1.00–1.01) 0.003
Histologic type 0.069
 Differentiated Reference
 Undifferentiated 1.22 (0.99–1.51)
Vascular invasion < 0.001 0.655
 Negative Reference
 Positive 1.69 (1.41–2.02)
Perineural invasion < 0.001 0.885
 Negative Reference
 Positive 1.63 (1.33–1.99)
pTNM stage < 0.001 < 0.001
 I Reference Reference
 II 2.65 (1.82–3.68) 2.00 (1.38–2.90)
 III 9.74 (7.05–13.46) 6.80 (4.91–9.41)
Adjuvant chemotherapy 0.260
 No Reference
 Yes 1.10 (0.93–1.31)
Hb < 0.001 0.003
  < 125 Reference Reference
  ≥ 125 0.51 (0.43–0.60) 0.77 (0.65–0.91)
LMR < 0.001 0.003
  < 3.4 Reference Reference
  ≥ 3.4 0.59 (0.50–0.70) 0.78 (0.65–0.91)
PLR < 0.001 0.434
  < 161.3 Reference
  ≥ 161.3 1.70 (1.44–2.00)